Search results for "Lung"

showing 10 items of 2389 documents

Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells

2022

PTHrP is encoded by PTHLH gene which can generate by alternative promoter usage and splicing mechanisms at least three mature peptides of 139, 141 and 173 amino acids with distinct carboxy terminus. PTHrP may undergo proteolytic processing into smaller bioactive forms, comprising an amino terminus peptide, which is the mediator of the "classical" PTH-like effect, as well as midregion and carboxy terminus peptides that act as multifaceted critical regulator of proliferation, differentiation and apoptosis via the reprogramming of gene expression in normal and neoplastic cells. Moreover, a nuclear/nucleolar localization signal sequence is present in the [87-107] domain allowing PTHrP nuclear i…

Parathyroid HormoneNeoplasmsParathyroid Hormone-Related ProteinHumansApoptosisSettore BIO/06 - Anatomia Comparata E CitologiaPeptidesTranscriptomeGene signatures Bone tumor Breast tumor Gastrointestinal tumor Prostate tumor Lung cancer Leukemia/lymphoma
researchProduct

Study of Beauty Hadron Decays into Pairs of Charm Hadrons

2014

First observations of the decays Λ[0 over b] → Λ[+ over c]D[− over (s)] are reported using data corresponding to an integrated luminosity of 3  fb[superscript −1] collected at 7 and 8 TeV center-of-mass energies in proton-proton collisions with the LHCb detector. In addition, the most precise measurement of the branching fraction B(B[0 over s] → D[superscript +]D[− over s]) is made and a search is performed for the decays B[0 over (s)] → Λ[+ over c]Λ[− over c]. The results obtained are B(Λ[0 over b] → Λ[+ over c]D[superscript −])/B(Λ[0 over b] → Λ[+ over c]D[− over s]) = 0.042 ± 0.003(stat) ± 0.003(syst), ⎡⎣B(Λ[0 over b] → Λ[+ over c]D[− over s]) over B([¯ over B[superscript 0] → D[superscr…

Particle physicsMesonHadronNuclear TheoryGeneral Physics and AstronomyFOS: Physical sciencesLHCb - Abteilung Hofmann13.30.-aSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - ExperimentNuclear physicsPhysics and Astronomy (all)High Energy Physics - Experiment (hep-ex)precise measurements14.20.Mr[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]TOOLCharm (quantum number)MASSESNuclear ExperimentQCBARYONSPhysicsLuminosity (scattering theory)Branching fractioncenter-of-mass energiesintegrated luminositybaryons; masses; toolParticle physicsBaryonproton proton collisionsLHCbprecise measurements; center-of-mass energies; tellurium compounds; integrated luminosity; hadrons; branching fractions; proton proton collisionshadronsDecays of baryonbranching fractionsBottom baryons (|B|>0)Física nuclearHigh Energy Physics::ExperimentLHCFísica de partículesExperimentstellurium compoundsTellurium compoundsParticle Physics - Experiment
researchProduct

Neutrinoless Double-Electron Capture

2020

Double-beta processes play a key role in the exploration of neutrino and weak interaction properties, and in the searches for effects beyond the Standard Model. During the last half century many attempts were undertaken to search for double-beta decay with emission of two electrons, especially for its neutrinoless mode ($0\nu2\beta^-$), the latter being still not observed. Double-electron capture (2EC) was not in focus so far because of its in general lower transition probability. However, the rate of neutrinoless double-electron capture ($0\nu2$EC) can experience a resonance enhancement by many orders of magnitude in case the initial and final states are energetically degenerate. In the re…

Particle physicsNuclear TheoryAtomic Physics (physics.atom-ph)Electron capturePhysics beyond the Standard ModelFOS: Physical sciencesdouble beta decayGeneral Physics and Astronomyhiukkasfysiikka7. Clean energy01 natural sciencesResonance (particle physics)neutrinoless double beta decayPhysics - Atomic PhysicsNuclear Theory (nucl-th)High Energy Physics - Phenomenology (hep-ph)0103 physical sciencesNuclear MatrixRoad mapNuclear Experiment (nucl-ex)010306 general physicsNuclear theoryNuclear Experimentnuclear tests of fundamental interactionsPhysics010308 nuclear & particles physicsBeta DecayBolometersHigh Energy Physics - PhenomenologyPräzisionsexperimente - Abteilung BlaumNeutrinoydinfysiikka
researchProduct

Beam-Helicity Asymmetries in Double-Charged-Pion Photoproduction on the Proton

2005

Beam-helicity asymmetries for the two-pion-photoproduction reaction gamma + p --> p pi+ pi- have been studied for the first time in the resonance region for center-of-mass energies between 1.35 GeV and 2.30 GeV. The experiment was performed at Jefferson Lab with the CEBAF Large Acceptance Spectrometer using circularly polarized tagged photons incident on an unpolarized hydrogen target. Beam-helicity-dependent angular distributions of the final-state particles were measured. The large cross-section asymmetries exhibit strong sensitivity to the kinematics and dynamics of the reaction. The data are compared with the results of various phenomenological model calculations, and show that these…

Particle physicsPhotonProtonGeneral Physics and AstronomyFOS: Physical sciences13.60.-r 13.60.Le 13.88.+e[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]01 natural sciencesHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Pion0103 physical sciencesPhenomenological model[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear Experiment (nucl-ex)010306 general physicsNuclear ExperimentNuclear ExperimentPhysics010308 nuclear & particles physicsBremsstrahlungHelicity3. Good healthPair productionNucleon
researchProduct

First observation of the doubly charmed baryon decay Ξcc++→Ξc+π+

2018

The doubly charmed baryon decay Ξcc++→Ξc+π+ is observed for the first time, with a statistical significance of 5.9σ, confirming a recent observation of the baryon in the Λc+K−π+π+ final state. The data sample used corresponds to an integrated luminosity of 1.7 fb−1, collected by the LHCb experiment in pp collisions at a center-of-mass energy of 13 TeV. The Ξcc++ mass is measured to be 3620.6±1.5(stat)±0.4(syst)±0.3(Ξc+) MeV/c2 and is consistent with the previous result. The ratio of branching fractions between the decay modes is measured to be [B(Ξcc++→Ξc+π+)×B(Ξc+→pK−π+)]/[B(Ξcc++→Λc+K−π+π+)×B(Λc+→pK−π+)]=0.035±0.009(stat)±0.003(syst).

Particles and fieldGeneral Physics and Astronomy01 natural sciencesNONuclear physicsPhysics and Astronomy (all)Condensed Matter::Superconductivity0103 physical sciencesPhysicLHCb - Abteilung HintonSDG 7 - Affordable and Clean Energy010306 general physicsPhysics/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energy010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyParticle physicsHEPBaryonLHCbCharmed baryonHadron colliderHigh Energy Physics::ExperimentB physics Branching fraction CP violation Hadron-Hadron scattering (experiments)LHCFísica de partículesExperiments
researchProduct

Measurement of the c0 Baryon Lifetime

2018

We report a measurement of the lifetime of the $��_c^0$ baryon using proton-proton collision data at center-of-mass energies of 7 and 8~TeV, corresponding to an integrated luminosity of 3.0 fb$^{-1}$ collected by the LHCb experiment. The sample consists of about 1000 $��_b^-\to��_c^0��^-\bar��_�� X$ signal decays, where the $��_c^0$ baryon is detected in the $pK^-K^-��^+$ final state and $X$ represents possible additional undetected particles in the decay. The $��_c^0$ lifetime is measured to be $��_{��_c^0} = 268\pm24\pm10\pm2$ fs, where the uncertainties are statistical, systematic, and from the uncertainty in the $D^+$ lifetime, respectively. This value is nearly four times larger than, …

Particles and fieldGeneral PhysicsMesonGeneral Physics and AstronomyFOS: Physical sciences01 natural sciences7. Clean energyOmega09 EngineeringNOLuminosityHigh Energy Physics - Experiment (hep-ex)Physics and Astronomy (all)0103 physical sciencesPhysicHeavy baryonTOOLSDG 7 - Affordable and Clean EnergyLHCb - Abteilung Hinton010306 general physicsINCLUSIVE WEAK DECAYS; DISCARDING 1/N(C); RULE; TOOL01 Mathematical SciencesQuantum chromodynamicsPhysics/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energy02 Physical Sciences010308 nuclear & particles physicsQuark modelParticle physicsState (functional analysis)HEPDISCARDING 1/N(C)BaryonLHCbHadron colliderHigh Energy Physics::ExperimentINCLUSIVE WEAK DECAYSLHCAtomic physicsFísica de partículesExperimentsRULECharm physics Oscillation Flavor physics Hadron-Hadron scattering
researchProduct

Study of W Boson Production in Association with Beauty and Charm

2015

The associated production of a W boson with a jet originating from either a light parton or heavy-flavor quark is studied in the forward region using proton-proton collisions. The analysis uses data corresponding to integrated luminosities of 1.0 and 2.0  fb[superscript -1] collected with the LHCb detector at center-of-mass energies of 7 and 8 TeV, respectively. The W bosons are reconstructed using the W → μν decay and muons with a transverse momentum, p[subscript T], larger than 20 GeV in the pseudorapidity range 2.0 20  GeV and 2.2 20  GeV. The fraction of W + jet events that originate from beauty and charm quarks is measured, along with the charge asymmetries of the W + b and W + c produ…

PartonATLAS DETECTOR01 natural sciencesPRODUCTION CROSS-SECTIONSHigh Energy Physics - ExperimentPhysics Particles & FieldsSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - Experiment (hep-ex)[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Charm (quantum number)Nuclear ExperimentBosonPhysicsPhysicsParticle physics14.70.FmPseudorapidityPhysical Sciences13.87.-aLHCParticle Physics - ExperimentQuarkNuclear and High Energy PhysicsParticle physicsCOLLISIONSAstrophysics::High Energy Astrophysical PhenomenaFOS: Physical sciencesLHCb - Abteilung HofmannHadronsAstronomy & AstrophysicsCharm quarkStandard ModelNOJets in large-Q2 scatteringNuclear physicsRATIO0103 physical sciencesSDG 7 - Affordable and Clean Energy010306 general physicsLarge Hadron Collider (France and Switzerland)MuonScience & Technology/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyROOT-S=7 TEV010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyGran Col·lisionador d'HadronsHEPLHCbJETSW bosonHigh Energy Physics::ExperimentFísica de partículesExperimentsDECAY
researchProduct

Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.

2013

Background: Prostaglandin E2 (PGE(2)), the main metabolite of cyclooxygenase (COX), is a well-known anti-fibrotic agent. Moreover, myofibroblasts expressing alpha-smooth muscle actin (alpha-SMA), fibroblast expansion and epithelial-mesenchymal transition (EMT) are critical to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Our aim was to investigate the expression of COX-2 and PGE(2) in human lung myofibroblasts and establish whether fibroblast-myofibroblast transition (FMT) and EMT are associated with COX-2 and PGE(2) down-regulation. Methods: Fibroblasts obtained from IPF patients (n = 6) and patients undergoing spontaneous pneumothorax (control, n = 6) and alveolar epithelial ce…

PathologyPulmonologyMetaboliteImmunofluorescencelcsh:MedicineBiochemistrychemistry.chemical_compoundIdiopathic pulmonary fibrosisMolecular Cell BiologyPulmonary fibrosisProstaglandin E2Myofibroblastslcsh:ScienceLungCells CulturedFisiologia cel·lularMultidisciplinarybiologyFibrosi pulmonarrespiratory systemExtracellular Matrixmedicine.anatomical_structureCytokinesMedicinelipids (amino acids peptides and proteins)Immunohistochemical AnalysisMyofibroblastResearch ArticleSignal Transductionmedicine.drugmedicine.medical_specialtyEpithelial-Mesenchymal TransitionImmunologyInterstitial Lung DiseasesDinoprostonePulmonary fibrosisTransforming Growth Factor beta1ImmunofluorescènciaGrowth FactorsCell Line TumormedicineHumansEpithelial–mesenchymal transitionFibroblastBiologyCell Proliferationlcsh:RProteinsEpithelial Cellsmedicine.diseaseActinsIdiopathic Pulmonary Fibrosisrespiratory tract diseasesGene Expression RegulationchemistryCyclooxygenase 2Immune SystemCase-Control StudiesImmunologic Techniquesbiology.proteinCancer researchClinical Immunologylcsh:QCyclooxygenaseBiomarkersPLoS ONE
researchProduct

IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease

2011

Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, gut, liver and lung. Both pro- and anti-inflammatory properties have been reported for IL-22 depending on the tissue and disease model. In a murine model of allergic airway inflammation, we found that IL-22 is predominantly produced by innate lymphoid cells in the inflamed lungs, rather than TH cells. To determine the impact of IL-22 on airway inflammation, we used allergen-sensitized IL-22-deficient mice and found that they suffer from significantly higher airway hyperreactivity upon airway challenge. IL-22-deficiency led to increased eosinophil infiltration lymphocyte invasion and production…

PathologyPulmonologymedicine.medical_treatmentT-LymphocytesIntracellular Spacelcsh:Medicine10263 Institute of Experimental ImmunologyInterleukin 22Mice0302 clinical medicineLymphocytesPhosphorylationlcsh:ScienceLung0303 health sciencesMultidisciplinaryInterleukin-13T CellsAllergy and HypersensitivityInnate lymphoid cellInterleukinrespiratory systemInnate ImmunityRecombinant Proteins3. Good healthCytokinemedicine.anatomical_structureInterleukin 13CytokinesMedicineTumor necrosis factor alphaBiological Markersmedicine.symptomResearch ArticleSTAT3 Transcription Factormedicine.medical_specialtyImmune CellsImmunologyAntigen-Presenting CellsImmunoglobulinsInflammation610 Medicine & health1100 General Agricultural and Biological SciencesBiology03 medical and health sciences1300 General Biochemistry Genetics and Molecular BiologymedicineRespiratory HypersensitivityAnimalsBiology030304 developmental biologyInflammation1000 MultidisciplinaryTumor Necrosis Factor-alphaInterleukinslcsh:RImmunityEpithelial CellsEosinophilAllergensAsthmaImmunity Innaterespiratory tract diseasesImmune SystemImmunology570 Life sciences; biologylcsh:QImmunizationBiomarkers030215 immunology
researchProduct

Predicting Lung Deposition of Extrafine Inhaled Corticosteroid-Containing Fixed Combinations in Patients with Chronic Obstructive Pulmonary Disease U…

2021

Background: Functional respiratory imaging (FRI) is a computational fluid dynamics-based technique using three-dimensional models of human lungs and formulation profiles to simulate aerosol deposition. Methods: FRI was used to evaluate lung deposition of extrafine beclomethasone dipropionate (BDP)/formoterol fumarate (FF)/glycopyrronium bromide (GB) and extrafine BDP/FF delivered through pressurized metered dose inhalers and to compare results with reference gamma scintigraphy data. FRI combined high-resolution computed tomography scans of 20 patients with moderate-to-severe chronic obstructive pulmonary disease (mean forced expiratory volume in 1 second 42% predicted) with in silico comput…

PathologyRespiratory SystemPharmaceutical ScienceINHALATION030226 pharmacology & pharmacyPulmonary Disease Chronic Obstructive0302 clinical medicineAdrenal Cortex HormonesFormoterol FumaratePharmacology (medical)1102 Cardiorespiratory Medicine and Haematologycombination drugLungBRONCHODILATOROriginal Researchlung depositionBeclomethasonerespiratory systemDrug CombinationsTreatment OutcomeCorticosteroid1115 Pharmacology and Pharmaceutical SciencesPMDILife Sciences & BiomedicineCombination drugPulmonary and Respiratory Medicinemedicine.medical_specialtyLung depositionextrafinemedicine.drug_classIn silicoPulmonary diseaseSettore MED/10 - Malattie Dell'Apparato Respiratorioinhaled corticosteroid03 medical and health sciencespressurized metered-dose inhalerAdministration InhalationmedicineHumansIn patientComputer SimulationSMALL AIRWAYScombination drug extrafine functional respiratory imaging inhaled corticosteroid lung deposition pressurized metered-dose inhalerScience & TechnologyRespiratory imagingbusiness.industryDYSFUNCTION030228 respiratory systemASTHMAfunctional respiratory imagingbusiness
researchProduct